Wegovy Semaglutide
£139.00
- In Stock
Wegovy® is the only weight management medication also approved for cardiovascular (CV) risk reduction in adults living with overweight or obesity and established cardiovascular disease (CVD) in addition to a reduced-calorie diet and increased physical activity in the UK
- 0.25mg
- 0.5mg
- 1.0mg
- 1.7mg
- 2.4mg
- Categories : Wellbeing
The active ingredient in Wegovy is semaglutide, a synthetic version of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). Semaglutide works by binding to GLP-1 receptors, which leads to increased insulin secretion in response to elevated blood glucose, decreased glucagon release, and slowed gastric emptying. These effects contribute to reduced appetite and better blood sugar regulation.
Semaglutide has been studied extensively for its effectiveness in weight management and type 2 diabetes. While it has shown promising results, ongoing studies continue to clarify its long-term safety profile and full range of benefits.
semaglutide is given as a once-weekly subcutaneous injection. The injection sites recommended are the abdomen, thigh, or upper arm, and patients should rotate these sites to minimize injection site reactions. The medication pen should be stored refrigerated between 2°C and 8°C and protected from freezing. Prior to injection, the pen should be allowed to reach room temperature (approximately 30 minutes) to ease the injection process. You can keep the pen for 6 weeks when stored at a temperature below 30°C or in a refrigerator (2°C to 8°C) away from cooling element. Do not use this medicine if you notice that the solution is not clear and colourless. Do not throw away any medicines via wastewater or household waste.
Treatment with semaglutide typically begins with a low dose, which is gradually increased every four weeks to help the body adjust and reduce side effects. Patients must carefully follow the dosing schedule and instructions provided by their healthcare provider. Proper injection technique and safe disposal of needles are important for safety.
semaglutide should be used alongside a reduced-calorie diet and increased physical activity to maximize its benefits. Patients are advised not to skip doses but to consult their healthcare provider if a dose is missed or if they have any concerns regarding administration.
The active substance is semaglutide. – The other ingredients are disodium phosphate dihydrate, propylene glycol,
Besides the active ingredient, semaglutide contains various excipients and preservatives that support the medication's stability and usability. These ingredients help maintain the medication’s safety profile during storage and administration. Patients should always check for potential allergies to any component before using the medication.
Wegovy is prescribed primarily for adults with obesity or overweight conditions who have at least one weight-related health problem such as hypertension, type 2 diabetes, or high cholesterol. It is intended to support weight loss as part of a comprehensive lifestyle program including diet and exercise.
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, and dizziness. Most side effects are mild to moderate and tend to decrease over time as the patient’s body adjusts to the medication. Maintaining adequate hydration can help alleviate some gastrointestinal symptoms.
There are potential rare but serious risks including thyroid tumors (including medullary thyroid carcinoma) and pancreatitis. Patients should discuss their personal and family medical history with their healthcare provider before starting Wegovy. Regular follow-ups and monitoring help ensure safe use and identify any adverse effects early.
Do not use wegovy if you are allergic to semaglutide or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions Talk to your doctor, pharmacist or nurse before using wegovy or during treatment if you have: • Effects on the digestive system During treatment with wegovy, you may feel sick (nausea) or be sick (vomiting), or have diarrhoea. These side effects can cause dehydration (loss of fluids). It is important that you drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. Talk to your doctor if you have any questions or concerns. • Inflammation of the pancreas If you have severe and on-going pain in the stomach area see a doctor straight away as this could be a sign of inflamed pancreas (acute pancreatitis). • Diabetes wegovy must not be used as a substitute for insulin. • Low blood sugar (hypoglycaemia) wegovy can cause low blood sugar. Please see section 4 for the warning signs of low blood sugar levels. If you have diabetes and are taking a sulfonylurea or an insulin with wegovy the risk of getting low blood sugar levels (hypoglycaemia) might increase. Your doctor may ask you to test your blood sugar levels. This will help your doctor decide if the dose of the sulfonylurea or insulin needs to be changed to reduce the risk of low blood sugar. • Diabetic eye disease (retinopathy) Fast improvements in blood sugar control may lead to a temporary worsening of diabetic eye disease. If you have diabetic eye disease and experience eye problems while taking this medicine, talk to your doctor. If you know that you are due to have surgery where you will be under anaesthesia (sleeping), please tell your doctor that you are taking wegovy.
Pregnancy and breast-feeding This medicine should not be used during pregnancy, as it is not known if it may affect your unborn child. Therefore, it is recommended to use contraception while using this medicine. Effective contraception includes oral (the pill) and non-oral (the implant, coil or condoms) forms of contraception. Those taking Mounjaro, who are overweight and using an oral form of contraception, are advised to also use a non-oral form. Mounjaro may reduce the effectiveness of oral contraceptives in those who are overweight.If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped. You should not use this medicine if you are breast-feeding, as it is unknown if it passes into breast milk.
Driving and using machines wegovy is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking wegovy mainly during the first 3 months of treatment (see section 4). If you feel dizzy you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Serious side effects Common: may affect up to 1 in 10 people • Complications of diabetic eye disease (diabetic retinopathy). If you have diabetes you should inform your doctor if you experience eye problems, such as changes in vision, during treatment with this medicine. Uncommon: may affect up to 1 in 100 people • Inflamed pancreas (acute pancreatitis). Signs of inflamed pancreas may include severe and longlasting pain in your stomach, the pain may move to your back. You should see your doctor immediately if you experience such symptoms. • Kidney or bladder stones. Signs may include back or lower abdomen pain, difficulty in urination or change in colour of your urine.
Related Products
